Deltex Medical Group's revenue for the
six
months ended in Dec. 2023 was £0.72 Mil.
Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was £1.78 Mil.
Deltex Medical Group's Revenue per Share for the
six
months ended in Dec. 2023 was £0.00.
Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was £0.00.
Warning Sign:
Deltex Medical Group PLC revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of Deltex Medical Group was -50.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -26.30% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -26.60% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -26.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, Deltex Medical Group's highest 3-Year average Revenue per Share Growth Rate was 47.10% per year. The lowest was -35.90% per year. And the median was -6.75% per year.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Deltex Medical Group's Revenue
For the Medical Devices subindustry, Deltex Medical Group's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Deltex Medical Group's Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Deltex Medical Group's Revenue distribution charts can be found below:
* The bar in red indicates where Deltex Medical Group's Revenue falls into.
Deltex Medical Group Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £1.78 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Deltex Medical Group (LSE:DEMG) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Deltex Medical Group Revenue Related Terms
Thank you for viewing the detailed overview of Deltex Medical Group's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Deltex Medical Group (LSE:DEMG) Business Description
Deltex Medical Group PLC is a British manufacturer of Fluid Management devices, which include the ODM and now ODM+ haemodynamic monitoring systems. It has developed the gold standard for haemodynamic monitoring with its oesophageal Doppler technology, which is marketed as TrueVue Doppler and often generically referred to by clinicians as ODM. The company's initial and principal technology is Doppler-based ultrasound oesophageal haemodynamic monitoring. This technology generates accurate, real-time data on descending aortic blood flow velocity in anesthetised or sedated patients.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LSE:DEMG has been successfully added to your 